Sign in

CIK 0001604821 · Large accelerated filer

Natera, Inc.

Sign in to watch
Ticker
NTRA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
010894487
Phone
650-249-9090
Business address
13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
Former names
Natera, Inc.
  1. 4 Grant or award Director acquired 91 shares (grant or award)
  2. 4 Grant or award Director acquired 97 shares (grant or award)
  3. 4 Grant or award Director acquired 112 shares (grant or award)
  4. 4 Grant or award Director acquired 70 shares (grant or award)
  5. 4 Grant or award Director acquired 70 shares (grant or award)
  6. 144 Insider Sale of Securities
  7. 144 Insider Sale of Securities
  8. 144 Insider Sale of Securities
  9. 4 Planned sale CEO AND PRESIDENT sold 5,970 shares at an average $238.78 ($1,425,506)
  10. 4 Planned sale CHIEF FINANCIAL OFFICER sold 5,064 shares at an average $235.38 ($1,191,953)
  11. 4 Planned sale Director sold 482 shares at an average $239.39 ($115,388)
  12. 4 Planned sale SEC. AND CHIEF LEGAL OFFICER sold 1,886 shares at an average $239.01 ($450,773)
  13. 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 2,213 shares at an average $238.98 ($528,853)
  14. 4 Planned sale PRESIDENT, CHIEF BUS. OFFICER sold 1,712 shares at an average $238.98 ($409,127)
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. 4 Planned sale Director sold 1,500 shares at an average $243.94 ($365,914)
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. 4 Planned sale CEO AND PRESIDENT sold 73,522 shares at an average $234.74 ($17,258,853)
  20. 4 Planned sale CHIEF FINANCIAL OFFICER sold 61,123 shares at an average $239.49 ($14,638,100)

Page 13 of 94 · 1,862 filings